 | Surface Oncology -2.1% after equity sales agreement
seekingalpha.com - May 22 at 7:40 PM |
 | P/E Ratio Insights for Surface Oncology
finance.yahoo.com - May 20 at 3:01 PM |
 | Why Surface Oncology's Stock Is Surging Higher
www.benzinga.com - May 20 at 1:00 PM |
 | Thinking about buying stock in Surface Oncology, Inovio Pharmaceuticals, American Airlines, Altimmune, or Aurora Cannabis?
www.prnewswire.com - May 20 at 10:01 AM |
| Surface Oncology teams up with Merck in cancer study; shares up 35%
seekingalpha.com - May 20 at 10:01 AM |
| Surface Oncology Fully Utilizes its $30M At-the-Market Facility
finance.yahoo.com - May 20 at 10:01 AM |
 | Surface Oncology Inc (NASDAQ:SURF) Short Interest Update
www.americanbankingnews.com - May 18 at 10:10 PM |
| Upgrade: Analysts Just Made A Massive Increase To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts
finance.yahoo.com - May 15 at 1:31 PM |
| Surface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual Meeting
finance.yahoo.com - May 15 at 8:30 AM |
| Surface Oncology to Present at the American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - May 14 at 9:41 AM |
|
| Surface Oncology (NASDAQ:SURF) Releases Earnings Results, Beats Estimates By $0.31 EPS
www.americanbankingnews.com - May 13 at 7:42 PM |
| Surface Oncology EPS beats by $0.54, beats on revenue
seekingalpha.com - May 12 at 8:08 AM |
| Surface Oncology Inc (SURF) to Report Q1 Results: Wall Street Expects Earnings Growth
finance.yahoo.com - May 7 at 2:54 PM |
| Surface Oncology launches early-stage study of cancer candidate SRF388
seekingalpha.com - April 23 at 1:42 PM |
| Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388
finance.yahoo.com - April 23 at 8:42 AM |
 | BRIEF-Surface Oncology Announces First Patient Dosed In Clinical Trial Of Immuno-Oncology Candidate SRF617
www.reuters.com - March 18 at 12:55 AM |
| Surface Oncology up 4% on start of SRF617 study
seekingalpha.com - March 17 at 2:54 PM |
| Earnings Beat: Surface Oncology, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
finance.yahoo.com - March 12 at 2:23 PM |
| Surface Oncology EPS in-line, misses on revenue
seekingalpha.com - March 10 at 9:08 AM |
| Is Surface Oncology (SURF) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - March 6 at 12:45 PM |
| Surface Oncology to Present at the 40th Annual Cowen Healthcare Conference
finance.yahoo.com - February 25 at 7:58 PM |
 | Molecular Partners AG: Molecular Partners Announces Newly Nominated Board Members for Upcoming Annual Meeting
www.finanznachrichten.de - February 20 at 7:29 AM |
| Is Surface Oncology (SURF) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - February 19 at 2:42 PM |
| Surface Oncology, Inc. (SURF) Shares March Higher, Can It Continue?
finance.yahoo.com - February 4 at 8:54 AM |
| The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
www.benzinga.com - January 28 at 9:38 AM |
| Surface Oncology to advance two candidates into the clinic; shares up 9% premarket
seekingalpha.com - January 28 at 9:38 AM |
| Surface Oncology +14% as FDA clears two INDs
seekingalpha.com - January 27 at 10:45 PM |
 | BRIEF-Surface Oncology Says Board Approved Corporate Restructuring
www.msn.com - January 27 at 10:45 PM |
|
| BRIEF-Surface Oncology Announces FDA Clearance Of SRF617 And SRF388 INDs To Initiate Phase 1 Clinical Trials
www.msn.com - January 27 at 5:44 PM |
| Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials
finance.yahoo.com - January 27 at 5:44 PM |
| Did Hedge Funds Drop The Ball On Surface Oncology, Inc. (SURF) ?
finance.yahoo.com - December 23 at 1:31 PM |
| Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference
finance.yahoo.com - November 26 at 8:19 AM |
| BRIEF-Surface Oncology Announces $25 Mln Debt Financing From K2 HealthVentures
www.msn.com - November 25 at 7:58 PM |
| Surface Oncology receives $25M in debt financing
seekingalpha.com - November 25 at 2:57 PM |
| Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
finance.yahoo.com - November 25 at 2:57 PM |
| Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
finance.yahoo.com - November 18 at 8:22 AM |
| Surface Oncology, Inc. (SURF) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 12 at 1:07 PM |
| Surface Oncology EPS misses by $0.03, misses on revenue
seekingalpha.com - November 12 at 8:06 AM |
| Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019
finance.yahoo.com - November 12 at 8:06 AM |
| Surface Oncology Presents Updates at the Society for Immunotherapy of Cancer’s Annual Meeting
finance.yahoo.com - November 7 at 12:19 PM |
| Kaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Investors - SURF
finance.yahoo.com - October 26 at 11:04 PM |
| Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City
finance.yahoo.com - October 7 at 9:03 AM |
| Here's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely
finance.yahoo.com - September 23 at 4:40 PM |
| Here's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely
finance.yahoo.com - September 23 at 4:40 PM |
| IPO INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
finance.yahoo.com - September 18 at 7:03 PM |
| The global CTLA4 inhibitors market at a CAGR of over 9% during the forecast period
www.benzinga.com - September 11 at 4:46 PM |
| IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
finance.yahoo.com - September 3 at 4:13 PM |
| Surface Oncology to Present at the Baird 2019 Global Healthcare Conference
finance.yahoo.com - September 3 at 4:13 PM |
| Ramy Ibrahim, M.D. to Join Surface Oncology Board of Directors
finance.yahoo.com - September 3 at 12:39 PM |
| ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - August 28 at 4:49 PM |
